ARA-290: Handling, Storage, and Reconstitution Guide

This guide covers laboratory handling, storage, and reconstitution of ARA-290 (cibinetide) as a lyophilized research peptide. Every step below is framed as laboratory best practice for in-vitro and animal-model preparation, not as human-use instruction.

ARA-290 Handling and Storage Fundamentals

ARA-290 ships as a solid, white lyophilized powder in a sealed glass vial. In lyophilized form it is stored at or below 25 degrees Celsius, sealed, and protected from heat, light, and moisture. For extended storage, keep the material lyophilized and refrigerated or frozen. Minimizing exposure to humidity and temperature swings preserves peptide integrity across a study.

Before opening a vial, confirm the material against its documentation: molecular formula C51H84N16O21, molecular weight approximately 1257.3 g/mol, and CAS number 1208243-50-8. Matching these to the certificate of analysis is the first traceability checkpoint and mirrors the verification described in the ARA-290 mechanism of action overview.

Because ARA-290 is supplied as a defined 11-residue peptide, its handling profile is that of a small, well-characterized lyophilized material. Standard peptide precautions apply, and the emphasis throughout is on preventing moisture uptake and thermal cycling, the two factors most likely to compromise a lyophilized preparation before it reaches the assay.

Reconstitution for In-Vitro Preparation

For laboratory preparation, lyophilized ARA-290 is typically reconstituted with bacteriostatic water or another solvent appropriate to the downstream assay. Introduce the diluent slowly against the inner wall of the vial rather than directly onto the powder, and allow the peptide to dissolve without vigorous agitation. Swirl gently; avoid shaking, which can shear the peptide and introduce foaming.

• Add diluent down the vial wall, not onto the powder pellet.
• Let the material dissolve gently; do not vortex aggressively.
• Inspect the solution for complete dissolution before use.
• Calculate concentration from the labeled mass and diluent volume.

Puritide supplies ARA-290 in a 10 mg vial, so working-stock concentration follows directly from the diluent volume chosen for the assay.

Aliquoting to Limit Freeze-Thaw

Repeated freeze-thaw cycles are a common source of peptide degradation. After reconstitution, divide the solution into single-use aliquots so each experiment draws from a vial thawed only once. Label every aliquot with the compound name, concentration, date, and lot number. This practice keeps signaling readouts comparable across replicates and protects the material that anchors ARA-290 research applications.

Cold-Chain and Working-Solution Storage

Store reconstituted aliquots frozen for longer holds, and keep any short-term working solution cold and protected from light. Maintain consistent conditions throughout the study period and monitor storage records as part of quality assurance. Documenting time-at-temperature for each aliquot supports reproducibility and audit readiness.

COA and Lot Verification

Each ARA-290 batch ships with a third-party-verified certificate of analysis documenting purity (HPLC / reverse-phase chromatography), mass-spectrometry identity confirmation, and lot, testing date, and method details. Verify the COA against the vial label before beginning work, and retain it with your batch records. Researchers may also request a sample COA ahead of purchase to confirm testing parameters.

PPE and Institutional Compliance

Handle ARA-290 as an investigational material. Follow institutional SOPs, chemical hygiene plans, and approved protocols; wear a lab coat, gloves, and eye protection; and use engineering controls where required. Qualified personnel should perform all handling in controlled environments in accordance with applicable regulations.

Consistency Across Related Peptides

Labs running several healing-recovery peptides benefit from a shared handling SOP. The reconstitution and cold-chain principles here align with the BPC-157 handling guide and the KPV handling guide, so a single documented workflow can cover multiple compounds. Full specification data is on the ARA-290 product page.

Verification also means matching the vial to its recorded synonyms, cibinetide, ARA290, and pHBSP among them, and confirming the expected white lyophilized appearance on receipt. Any deviation in appearance or labeling is worth resolving before reconstitution, since catching a discrepancy at intake is far less costly than discovering it after a preparation has entered an assay.

Building a Traceable Record

Traceability turns a single ARA-290 preparation into reproducible data. A complete record links the vial lot number to its certificate of analysis, notes the reconstitution solvent and final concentration, and logs each aliquot's storage temperature and freeze-thaw count. When results are later reviewed or independently repeated, this chain of documentation is what allows a preparation to be reconstructed exactly.

Laboratories running ARA-290 across multiple studies benefit from a standing log that captures these details in one place. Recording the calculated concentration alongside the labeled mass and diluent volume also guards against transcription errors, keeping the material behind every signaling readout consistent and auditable throughout the study period.

Consistent handling is ultimately a reproducibility measure. A ARA-290 preparation that is verified against its certificate of analysis, reconstituted gently, aliquoted to limit freeze-thaw, stored under stable cold-chain conditions, and fully documented gives every downstream experiment the same reliable starting material. That consistency is what allows independent laboratories to compare results and build on one another's work with confidence. When a study later proves difficult to reproduce, a complete handling record is often what lets investigators distinguish a genuine biological difference from a preparation artifact, which is why the effort invested in disciplined ARA-290 handling repays itself throughout a project.

For research use only. These handling notes describe laboratory practice for ARA-290 as a research material supplied by Puritide Research. ARA-290 is not approved for human or veterinary use, and nothing here constitutes medical or administration guidance.